What types of transactions are classifed as ‘corporate reorganisations’ in your jurisdiction?
The term ‘corporate reorganisation’ can be used to mean a wide variety of transactions, but is most typically used to refer to...more
Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the...more
2/10/2022
/ Clinical Trials ,
Digital Health ,
EU ,
EU Clinical Trials Regulation (CTR) ,
Health Care Providers ,
Joint Venture ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Standards ,
UK ,
Venture Capital
Proposed changes to the UK Listing Rules would allow certain SPACs to avoid a listing suspension.
Key Points:
..The FCA is proposing to amend its rules so that SPACs meeting certain conditions and disclosure...more
What types of transactions are classified as ‘corporate reorganisations’ in your jurisdiction?
The term ‘corporate reorganisation’ can be used to mean a wide variety of transactions, but is most typically used to refer to...more
Buyout firms planning an acquisition or preparing a portfolio company for exit must consider the impact of poor corporate culture, particularly on a potential IPO.
No institution, whatever its geography, industry, sector,...more
The scheme opens on 20 May 2020 and is available on a “first come, first served” basis.
On 18 May 2020, the UK government released a draft of its convertible loan note agreement and details of the application process for...more
The UK government is pledging at least £250 million in convertible loan notes to UK-registered businesses.
On 20 April 2020, the UK government issued a press release announcing a new Future Fund scheme for the financing of...more
‘Corporate reorganisation’ is something of an umbrella term, and is used in many different contexts to mean a multitude of different things. At one extreme, a reorganisation may refer to ‘paper’ changes to a corporate group’s...more
6/5/2019
/ Corporate Restructuring ,
Corporate Taxes ,
Debt Restructuring ,
EU ,
EU Passport ,
Financial Accounting ,
Insolvency ,
Internal Controls ,
Jurisdiction ,
Regulatory Standards ,
Shareholder Approval ,
UK ,
UK Brexit
The guidance provides helpful clarity on key regulatory changes impacting life sciences companies in the event of a no-deal Brexit.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published a...more
4/4/2019
/ Article 50 Treaty of the EU ,
EU ,
European Economic Area (EEA) ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
New Guidance ,
New Legislation ,
No-Deal Brexit ,
Pharmaceutical Industry ,
Time Extensions ,
UK ,
UK Brexit ,
Withdrawal Agreement
Britain’s decision to leave the European Union in June 2016, coupled with the election of Donald Trump as US president in November 2016, gave dealmakers plenty of pause for thought last year – but ultimately did little to...more